Evolutionary Tree Capital Management’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-9,259
Closed -$1.72M 29
2024
Q4
$1.72M Sell
9,259
-1,170
-11% -$227K 1.75% 24
2024
Q3
$2.2M Sell
10,429
-371
-3% -$64.5K 2.2% 21
2024
Q2
$1.45M Sell
10,800
-566
-5% -$107K 1.49% 28
2024
Q1
$2.44M Sell
11,366
-3,073
-21% -$602K 2.46% 16
2023
Q4
$2.94M Sell
14,439
-2,230
-13% -$361K 3.24% 10
2023
Q3
$3.31M Buy
16,669
+3,671
+28% +$926K 4.27% 7
2023
Q2
$4.22M Sell
12,998
-1,282
-9% -$366K 5.08% 5
2023
Q1
$3.34M Sell
14,280
-13,667
-49% -$3.45M 4.63% 7
2022
Q4
$7.04M Buy
27,947
+7,619
+37% +$1.62M 6.76% 3
2022
Q3
$3.61M Buy
+20,328
New +$4.08M 3.47% 10

Other funds holding INSP

Evolutionary Tree Capital Management's INSP Position: Q1 2025 in Review

Evolutionary Tree Capital Management sold out of Inspire Medical Systems (INSP) in Q1 2025, closing a stake of 9,259 shares — an estimated $1.72M sold.

Evolutionary Tree Capital Management first reported a position in INSP in Q3 2022 and held it in 10 quarters. The position peaked at $7.04M in Q4 2022. 363 funds tracked by Wall St. Rank hold INSP as of Q1 2025.

  • Evolutionary Tree Capital Management reported no remaining Inspire Medical Systems position as of Q1 2025 after selling out during the quarter.
  • Evolutionary Tree Capital Management sold 9,259 Inspire Medical Systems shares in Q1 2025, an estimated $1.72M.
  • Evolutionary Tree Capital Management first reported a position in Inspire Medical Systems in Q3 2022 and held it in 10 quarters.
  • Evolutionary Tree Capital Management's Inspire Medical Systems position peaked at $7.04M in Q4 2022.
  • 363 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q1 2025.

Based on Evolutionary Tree Capital Management's 13F filing for Q1 2025, filed 9 May 2025.